Merrimack Pharmaceuticals Stock Price on February 8, 2018

MACK Stock  USD 14.80  0.05  0.34%   
Below is the normalized historical share price chart for Merrimack Pharmaceuticals extending back to March 29, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Merrimack Pharmaceuticals stands at 14.80, as last reported on the 28th of March, with the highest price reaching 14.84 and the lowest price hitting 14.80 during the day.
IPO Date
29th of March 2012
200 Day MA
12.8699
50 Day MA
14.1952
Beta
1.413
 
Yuan Drop
 
Covid
If you're considering investing in Merrimack Stock, it is important to understand the factors that can impact its price. We consider Merrimack Pharmaceuticals not too volatile. Merrimack Pharmaceuticals has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. We have found thirty technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Risk Adjusted Performance of 0.0874, downside deviation of 0.7005, and Mean Deviation of 0.6607 to check out if the risk estimate we provide is consistent with the expected return of 0.17%.
  
At this time, Merrimack Pharmaceuticals' Total Stockholder Equity is quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 1.8 M this year, although the value of Other Stockholder Equity will most likely fall to about 507.8 M. . At this time, Merrimack Pharmaceuticals' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 6.84 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (119.69). Merrimack Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1363

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMACK
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.25
  actual daily
11
89% of assets are more volatile

Expected Return

 0.17
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
10
90% of assets perform better
Based on monthly moving average Merrimack Pharmaceuticals is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merrimack Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
11.449
Book Value
1.306
Enterprise Value
195.8 M
Enterprise Value Ebitda
(89.96)
Shares Float
9.4 M

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Merrimack Pharmaceuticals Stock history

Merrimack Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Merrimack is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Merrimack Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Merrimack Pharmaceuticals stock prices may prove useful in developing a viable investing in Merrimack Pharmaceuticals
Last ReportedProjected for 2024
Common Stock Shares Outstanding14.3 M10.9 M
Net Loss-1.8 M-1.9 M

Merrimack Pharmaceuticals Quarterly Net Working Capital

18.74 Million

Merrimack Pharmaceuticals Stock Technical Analysis

Merrimack Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Merrimack Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Merrimack Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Merrimack Pharmaceuticals Period Price Range

Merrimack Pharmaceuticals March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Merrimack Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Merrimack Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Merrimack Pharmaceuticals stock market strength indicators, traders can identify Merrimack Pharmaceuticals entry and exit signals to maximize returns

Merrimack Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Merrimack Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Merrimack Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Merrimack to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Merrimack Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merrimack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merrimack Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Merrimack Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merrimack Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.
Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Merrimack Stock analysis

When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.08)
Return On Assets
(0.07)
Return On Equity
(0.06)
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.